期刊文献+

我国非ST段抬高急性冠状动脉综合征患者猝死或心律失常死亡事件危险因素分析 被引量:10

Risk factors of sudden death and death from arrhythmia in patients with non-ST elevation acute coronary syndromes in China
下载PDF
导出
摘要 目的 研究分析 OASIS登记试验中国地区所有入选的非 ST段抬高急性冠状动脉综合征(ACS)患者 2年随访结束时 ,猝死及心律失常死亡事件的发生及与多种因素之间的关系。方法 总结所有入选患者从入院至 2年随访结束时主要死亡事件的发生情况及生存时间 ,并采用生存分析 (Cox回归 )模型 ,分析患者就诊时一般情况、既往病史、住院与随访期间治疗及不良事件发生等 77种因素在患者生存时间中所起的作用。结果 共注册 ACS患者 2 2 94例 ,总死亡数为 174例 ,主要死因为猝死或心律失常 (占 5 2 .9% )。增加死亡的主要危险因素有 :出院后随访期间的心肌梗死 (心梗 )频数 ,首次住院期间 2 4 h内心梗事件 ,首次住院期间心力衰竭事件 ,既往心梗病史 ,首次住院期间复发性心绞痛 ,首次住院天数 ,患者年龄。减少死亡的保护因素有 :出院后随访期间应用硝酸酯类药物频数 ,出院后随访期间应用抗血小板药物频数 ,出院后随访期间应用 β受体阻滞剂频数。结论 我国非 ST段抬高 ACS患者 2年随访中以猝死或心律失常死亡为第一位死因 ,死亡主要与患者冠心病严重程度和年龄有关。药物治疗 ,特别是硝酸酯类药物、阿司匹林和 β受体阻滞剂对主要死亡有保护作用。 Objective To analyze the relationship between sudden death and death from arrhythmia and multiple risk factors in patients with nonST elevation acute coronary syndromes in two years of followup in China. Methods This study was a part of an international multicentre registry Organization to Assess Strategies for Ischemic Syndromes(OASIS) . The patients admitted to the hospital with nonST elevation acute coronary syndrome were enrolled. No particular intervention was given for the treatment. All patients had been followedup for two years. The patients' clinical characteristics, therapeutic regimes and major events during hospitalization and two years' followup period were recorded by filling in Case Report Forms according to the protocol offered by Canadian Cardiovascular Collaboration. Cox regression model was used to analyze the association with the most common causes of death and multiple factors recorded. Results From April 1999 to December 2001, 2 294 cases were enrolled in 38 hospitals in China nationwide. Among them 2 188 patients two years followup was accomplished. The mean age of the patients was (62 8± 8 1)years . Male gender was dominant (62 3%). The clinical diagnosis at admission was unstable angina in 88 5% of the patients and non Qwave myocardial infarction(MI) in the remaining 11 5%. The mortality was 7 6% with total deaths of 174 by the end of 24month follow up. The most common cause of death was severe arrhythmias or sudden death (92 cases, 52 9%). More than 70 factors were analyzed by Cox regression model in order to determine which were the predominant factors of death. Major risk factors that predisposed to death were: number of episodes of MI during followup period, reMI within 24 hours during hospitalization, heart failure during hospitalization, previous history of MI, recurrent angina pectoris during hospitalization, the duration of hospitalization, and patient age. Protective factors that reduced the chance of death were: the frequency of using nitrate, frequency of taking antiplatelet medicine or βblocker during followup period. Conclusion In China, the most common cause of death in patients with nonST elevation acute coronary syndromes is severe arrhythmias or sudden death, and it is related with the severity of coronary artery disease and the age of patients in majority of cases. Some factors that influence survival are similar to those established by previous evidence based medicine.
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2005年第3期142-145,共4页 Chinese Critical Care Medicine
基金 国际多中心研究课题 OASIS登记试验
关键词 中国 ST段 急性冠状动脉综合征 猝死 心律失常 死亡 心电图 阿司匹林 non-ST elevation acute coronary syndrome arrhythmia dead cause Cox regression
  • 相关文献

参考文献13

  • 1Piegas L S, Flather M ,Pogue J,et al. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina[J]. Am J Cardiol, 1999,84 : 7M - 12M.
  • 2赵玉生,王士雯,卢才义,吴兴利,李玉峰,刘玲玲,晏沐阳,程芮.急性心肌梗死并发心源性休克的临床特征与救治[J].中国危重病急救医学,2004,16(3):148-150. 被引量:49
  • 3Newby L K,Bhapkar M V,White H D,et al. Predictors of 90 -day outcome in patients stabilized after acute coronary syndromes[J]. Eur Heart J,2003,24:172- 181.
  • 4Theroux P, Fuster V. Acute coronary syndromes :unstable angina and non - Q - wave myocardial infarction [J]. Circulation, 1998,97:1195 - 1206.
  • 5Cohen M, Demers C,Gurfinkel E P, et al. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease: efficacy and safety of subcutaneous enoxparin in non - Q - wave coronary events study group [J].N Engl J Med,1997,337:447- 452.
  • 6Spencer F A,Santopinto J J,Gore J M,et al. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events[GRACE] [J]. Am J Cardiol, 2002,90: 1056 - 1061.
  • 7Chang W C,Harrington R A,Simoons M L,et al. Does eptifibatide confer a greater benefit to patients with unstable angina than with non- ST segment elevation myocardial infarction?Insights from the PURSUIT trial [J]. Eur Heart J, 2002, 23:1102-1111.
  • 8Gurfinkel E P, Manos E J, Mejail R I,et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia [J]. J Am Coll Cardiol,1995,26:313 - 318.
  • 9The SYNERGY Executive Committee. Superior yield of the new strategy of enoxaparin, revascularization and glycoprotein Ⅱb/Ⅲa inhibitors. The SYNERGY trial: study design and rationale [J]. Am Heart J, 2002,143 : 952 - 960.
  • 10The Heart Outcomes Prevention Evaluation Study Investigators.Effects of an angiotensin - converting - enzyme inhibitor,ramipril, on cardiovascular events in high - risk patients [J].N Engl J Med,2000,342:145- 153.

二级参考文献10

  • 1Williams S G,Wright D J, Tan L B. Management of cardiogenic shock complicating acute myocardial infarction : towards evidence based medical practice[J]. Heart, 2000,83 : 621 - 626.
  • 2Hochman J S,Boland J, Sleeper L A. Current spectrum of cardiogenic shock and effect of early revasculation on mortality:results of an international registry [J]. Circulation, 1995,91 : 873 - 881.
  • 3Sanborn T A,Sleeper L A,Bates E R. Impact of thrombosis,intra-ortic ballon pump conterpulsation and their combination in cardiogenic shock complicating acute myocardial infarction:a report from the shock trial registry[J]. J Am Coil Cardiol,2000,36(3 SupplA):1123 - 1129.
  • 4Williams S G,Wright D J,Tan L B.Management of cardiogenic shock complicating acute myocardial infarction:towards evidence based medical practice[J].Heart,2000,83:621-626.
  • 5Hochman J S,Boland J,Sleeper L A.Current spectrum of cardiogenic shock and effect of early revasculation on mortality:results of an international registry[J].Circulation,1995,91:873-881.
  • 6Sanborn T A, Sleeper L A, Bates E R. Impact of thrombosis, intra-aortic ballon pump conterpulsation and their combination in cardiogenic shock complicating acute myocardial infarction:a report from the shjock trial registry[J].J Am Coll Cardiol, 2000,36(3
  • 7.
  • 8.
  • 9冯斌,赵玉生,王宇枚,王士雯.大剂量654-Ⅱ救治高龄心力衰竭并感染性休克一例[J].中华老年心脑血管病杂志,2001,3(4):285-285. 被引量:1
  • 10黄体钢.急性心肌梗死合并心源性休克的理论和实践[J].中国危重病急救医学,2002,14(4):246-251. 被引量:36

共引文献48

同被引文献118

引证文献10

二级引证文献174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部